You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRAF rearrangement

Showing 26 - 50 of 562
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023

MPN (Myeloproliferative Tumors) Trial in Worldwide (Pemigatinib)

Active, not recruiting
  • MPN (Myeloproliferative Neoplasms)
  • Phoenix, Arizona
  • +32 more
Jun 24, 2022

Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)

Recruiting
  • Metastatic or Locally Advanced Malignancies
  • Berlin, Germany
  • +5 more
Jan 2, 2023

Metastatic Colorectal Cancer Trial in Houston (Cetuximab, Ulixertinib, Encorafenib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Scottsdale, Arizona
  • +2 more
Jan 4, 2023

Melanoma Trial (Blood samples, Skin biopsy)

Not yet recruiting
  • Melanoma
  • Blood samples
  • Skin biopsy
  • (no location specified)
Oct 3, 2022

BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer

Recruiting
  • Metastatic Non-small Cell Lung Cancer
  • BRAF V600 Mutation
    • Lyon, Rhône Alpes, France
      CHU Lyon - Hôpital Cardio-Vasculaire et Pneumologique Louis Prad
    Sep 14, 2022

    Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

    Recruiting
    • Melanoma (Skin)
    • +3 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Dec 30, 2022

    MRD Detection by NGS in Pediatric B-ALL

    Completed
    • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
    • MRD
    • Hangzhou, Zhejiang, China
      The Children's Hospital of Zhejiang University School of Medicin
    Jul 25, 2023

    Advanced Solid Tumor, BRAF V600 Mutation Trial in United States (ABM-1310, Cobimetinib)

    Recruiting
    • Advanced Solid Tumor
    • BRAF V600 Mutation
    • San Francisco, California
    • +3 more
    Dec 30, 2022

    First Line Treatment for BRAFV600E Mutant Metastatic Colorectal

    Completed
    • BRAF V600E Mutation Positive
    • Metastatic Colorectal Cancer
    • Non Interventional study
    • St. Veit/Glan, Austria
    • +33 more
    Jan 20, 2023

    Melanoma Trial in Italy (dabrafenib, Trametinib)

    Recruiting
    • Melanoma
    • Meldola, Forlì-Cesena, Italy
    • +15 more
    Mar 18, 2022

    LIquid BIopsies in Patients Presenting Non-small Cell Lung

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Annecy, France
      • +7 more
      Oct 7, 2021

      Cancer Harboring BRAF Alterations Trial (FORE8394, Cobicistat)

      Not yet recruiting
      • Cancer Harboring BRAF Alterations
      • (no location specified)
      Aug 15, 2022

      Melanoma Trial in Boston, Harrison, New York (Dabrafenib, Trametinib, Phenformin)

      Active, not recruiting
      • Melanoma
      • Boston, Massachusetts
      • +2 more
      Jun 14, 2022

      Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and

      Recruiting
      • Unresectable Colon Cancer Peritoneal Metastases
      • PMMR/Ras/BRAF Wild-type
      • Serplulimab Combined With FOLFIRI and Bevacizumab
      • Huzhou, Zhejiang, China
        Changxing County People's Hospital
      Feb 14, 2023

      Colo-rectal Cancer Trial (biological, drug, procedure)

      Not yet recruiting
      • Colo-rectal Cancer
      • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
      • +8 more
      • (no location specified)
      Aug 28, 2023

      Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

      Completed
      • Colorectal Cancer Metastatic
      • Targeted agent
      • (no location specified)
      Aug 31, 2023

      Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • Cetuximab + Envafolimab + mFOLFOXIRI
      • Cetuximab + mFOLFOX6/FOLFIRI
      • (no location specified)
      Jul 24, 2023

      NSCLC (NSCLC) Trial in Worldwide (Pemigatinib)

      Recruiting
      • Non-Small Cell Lung Cancer (NSCLC)
      • Los Angeles, California
      • +41 more
      Jun 27, 2022

      NSCLC, Stage III, ALK-rearrangement Trial in Worldwide (Brigatinib, Durvalumab)

      Not yet recruiting
      • NSCLC, Stage III
      • ALK-rearrangement
      • Angers, France
      • +19 more
      Feb 8, 2023

      Metastatic Colorectal Cancer Trial (ZN-c3, Encorafenib, Cetuximab)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • (no location specified)
      Feb 15, 2023

      ALK Phosphorylation Trial in Harbin (crizotinib for rearrangement-negative, high phosphorylated ALK patients)

      Completed
      • ALK Phosphorylation
      • crizotinib for rearrangement-negative, high phosphorylated ALK patients
      • Harbin, Heilongjiang, China
        Harbin Medical University Cancer Hospital
      Mar 19, 2023

      Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

      Completed
      • Metastatic Melanoma
      • East Hanover, New Jersey
        Novartis Investigative Site
      Nov 11, 2022

      Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas Trial in Canada, United States (Vemurafenib)

      Active, not recruiting
      • Pediatric Recurrent/Refractory BRAFV600E-mutant Gliomas
      • Los Angeles, California
      • +20 more
      Jan 4, 2023